IAVI 011

Status:Completed

Phase:I

Principal Investigator(s):

Objective:To evaluate a pox-viral vector vaccine.

Prevention Option(s):HIV Vaccine

Study Design:

Arms and Assigned Interventions

Description

Mode of Delivery

ARMs

Official Code: IAVI 011

Trial Sponsors: Division of Immunology and Allergy Lausanne Switzerland, Medical Research Council (MRC), Perinatal HIV Research Unit (PHRU), Simbec Research Limited-Merthyr Tydfil

Start Date

End Date

none

Enrollment:81

Age range: ↔ any

Population:

Stay up-to-date!